Coronary artery disease and familial hypercholesterolaemia patients' eligibility for pcsk-9 inhibitors: who is to benefit from lower ldl thresholds?
Event:
ESC Congress 2021 - The Digital Experience
Topic:
Lipids
Session:
Risk Factors and Prevention ePosters
